Pheochromocytoma and paraganglioma (PPGL) require prompt consideration and efficient
diagnosis and treatment to minimize associated morbidity and mortality. Once considered …

This article aims to review current concepts in diagnosing and managing
pheochromocytoma and paraganglioma (PPGL). Personalized genetic testing is vital, as 40 …

Pheochromocytomas/paragangliomas (PPGL) are rare, metastatic, and potentially fatal
neuroendocrine tumors, often neglected because they present symptoms similar to other …

Simple Summary Adrenocortical cancer is a very rare form of endocrine cancer with dismal
prognosis. Preclinical models such as cell lines, organoids, and mouse models are essential …

Pheochromocytoma/paraganglioma (PPGL) is an endocrine-related tumor associated with
excessive catecholamine release and has limited treatment options once metastasis occurs …

Diagnosis of pheochromocytoma or paraganglioma (PPGL) in pregnancy has been
associated historically with high rates of materno-fetal morbidity and mortality. Recent …

Objective The aim of this review is to provide a practical approach for clinicians regarding
the diagnosis and management of pheochromocytomas and paragangliomas (PPGL) …

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors
originating from chromaffin cells, holding significant clinical importance due to their capacity …

Introduction Pheochromocytoma is a rare catecholamine-producing neuroendocrine tumor
originating from the adrenal medulla chromaffin cells. Hemodynamic instability can occur …

Simple Summary Pheochromocytoma and sympathetic paraganglioma (PHEO/sPGL) are
rare and mainly sporadic tumors arising from chromaffin cells, for which hereditary variants …